This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazumder, S.
Right arrow Articles by Almasan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazumder, S.
Right arrow Articles by Almasan, A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2002, p. 2398-2409, Vol. 22, No. 7
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.7.2398-2409.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Proteolytic Cleavage of Cyclin E Leads to Inactivation of Associated Kinase Activity and Amplification of Apoptosis in Hematopoietic Cells

Suparna Mazumder,1 Bendi Gong,1 Quan Chen,1 Judith A. Drazba,2 Jeffrey C. Buchsbaum,3 and Alexandru Almasan1,3*

Department of Cancer Biology, Lerner Research Institute ,1 Department of Radiation Oncology,3 Imaging Core, The Cleveland Clinic Foundation, Cleveland, Ohio 441952

Received 6 June 2001/ Returned for modification 18 July 2001/ Accepted 17 December 2001

Cyclin E/Cdk2 is a critical regulator of cell cycle progression from G1 to S in mammalian cells and has an established role in oncogenesis. Here we examined the role of deregulated cyclin E expression in apoptosis. The levels of p50-cyclin E initially increased, and this was followed by a decrease starting at 8 h after treatment with genotoxic stress agents, such as ionizing radiation. This pattern was mirrored by the cyclin E-Cdk2-associated kinase activity and a time-dependent expression of a novel p18-cyclin E. p18-cyclin E was induced during apoptosis triggered by multiple genotoxic stress agents in all hematopoietic tumor cell lines we have examined. The p18-cyclin E expression was prevented by Bcl-2 overexpression and by the general caspase and specific caspase 3 pharmacologic inhibitors zVAD-fluoromethyl ketone (zVAD-fmk) and N-acetyl-Asp-Glu-Val-Asp-aldehyde (DEVD-CHO), indicating that it was linked to apoptosis. A p18-cyclin E276-395 (where cyclin E276-395 is the cyclin E fragment containing residues 276 to 395) was reconstituted in vitro, with mutagenesis experiments, indicating that the caspase-dependent cleavage was at amino acid residues 272 to 275. Immunoprecipitation analyses of the ectopically expressed cyclin E1-275, cyclin E276-395 deletion mutants, and native p50-cyclin E demonstrated that caspase-mediated cyclin E cleavage eliminated interaction with Cdk2 and therefore inactivated the associated kinase activity. Overexpression of cyclin E276-395, but not of several other cyclin E mutants, specifically induced phosphatidylserine exposure and caspase activation in a dose-dependent manner, which were inhibited in Bcl-2-overexpressing cells or in the presence of zVAD-fmk. Apoptosis and generation of p18-cyclin E were significantly inhibited by overexpressing the cleavage-resistant cyclin E mutant, indicating a functional role for caspase-dependent proteolysis of cyclin E for apoptosis of hematopoietic tumor cells.


* Corresponding author. Mailing address: Departments of Cancer Biology and Radiation Oncology, Lerner Research Institute, NB40, Cleveland Clinic Foundation, Cleveland, OH 44195. Phone: (216) 444-9970. Fax: (216) 445-6269. E-mail: almasaa{at}ccf.org.


Molecular and Cellular Biology, April 2002, p. 2398-2409, Vol. 22, No. 7
0022-538X/02/$04.00+0     DOI: 10.1128/MCB.22.7.2398-2409.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Ugland, H., Boquest, A. C., Naderi, S., Collas, P., Blomhoff, H. K. (2008). cAMP-mediated Induction of Cyclin E Sensitizes Growth-arrested Adipose Stem Cells to DNA Damage-induced Apoptosis. Mol. Biol. Cell 19: 5082-5092 [Abstract] [Full Text]  
  • Plesca, D., Mazumder, S., Gama, V., Matsuyama, S., Almasan, A. (2008). A C-terminal Fragment of Cyclin E, Generated by Caspase-mediated Cleavage, Is Degraded in the Absence of a Recognizable Phosphodegron. J. Biol. Chem. 283: 30796-30803 [Abstract] [Full Text]  
  • Truscott, M., Denault, J.-B., Goulet, B., Leduy, L., Salvesen, G. S., Nepveu, A. (2007). Carboxyl-terminal Proteolytic Processing of CUX1 by a Caspase Enables Transcriptional Activation in Proliferating Cells. J. Biol. Chem. 282: 30216-30226 [Abstract] [Full Text]  
  • Mazumder, S., Plesca, D., Kinter, M., Almasan, A. (2007). Interaction of a Cyclin E Fragment with Ku70 Regulates Bax-Mediated Apoptosis. Mol. Cell. Biol. 27: 3511-3520 [Abstract] [Full Text]  
  • Ray, S., Shyam, S., Fraizer, G. C., Almasan, A. (2007). S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells. Molecular Cancer Therapeutics 6: 1368-1378 [Abstract] [Full Text]  
  • Tzankov, A., Gschwendtner, A., Augustin, F., Fiegl, M., Obermann, E. C., Dirnhofer, S., Went, P. (2006). Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.. Clin. Cancer Res. 12: 2125-2132 [Abstract] [Full Text]  
  • Finkielstein, C. V., Chen, L. G., Maller, J. L. (2002). A Role for G1/S Cyclin-dependent Protein Kinases in the Apoptotic Response to Ionizing Radiation. J. Biol. Chem. 277: 38476-38485 [Abstract] [Full Text]